Arbutus Biopharma (ABUS) Free Cash Flow Growth (1y) (2014 - 2026)
Arbutus Biopharma (ABUS) Free Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 7.12% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,092.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 66.37% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.98% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - | 39.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.44% |
| Dec 31, 2025 | 55.00% |
| Sep 30, 2025 | 71.95% |
| Jun 30, 2025 | -8.58% |
| Mar 31, 2025 | 30.94% |
| Dec 31, 2024 | 39.85% |
| Sep 30, 2024 | 4.95% |
| Jun 30, 2024 | 28.96% |
| Mar 31, 2024 | 29.28% |
| Dec 31, 2023 | -0.98% |
| Sep 30, 2023 | -16.15% |
| Jun 30, 2023 | 0.42% |
| Mar 31, 2023 | -233.46% |
| Dec 31, 2022 | 12.92% |
| Sep 30, 2022 | -16.98% |
| Jun 30, 2022 | -40.05% |
| Mar 31, 2022 | 214.26% |
| Dec 31, 2021 | -29.67% |
| Sep 30, 2021 | -31.77% |
| Jun 30, 2021 | -65.12% |